Immunosuppressant treatment in refractory myositis. Our experience;La terapia immunosoppressiva nelle miositi refrattarie. Nostra esperienza

Recenti Progressi in Medicina

Volumn 100, Issue 10, 2009, Pages 451-457

  Danieli, Maria Giovanna ^a   Spalletta, Claudio ^a   Moretti, Romina ^a   Calabrese, Vincenzina ^a   Marchetti, Annalisa ^a   Gabrielli, Armando ^a   Logullo, Francesco ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Cyclophosphamide; Cyclosporine A; Dermatomyositis; Immunoglobulins; Methotrexate; Mycophenolate mofetil; Polymyositis

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CREATININE BLOOD LEVEL; DERMATOMYOSITIS; EPIGASTRIC PAIN; FEMALE; FOLLOW UP; GINGIVA HYPERPLASIA; HEADACHE; HIRSUTISM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NAUSEA; NAUSEA AND VOMITING; POLYMYOSITIS; REMISSION; SIDE EFFECT; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; DERMATOMYOSITIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 72449125181     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bohan A, Peter JB. Polymyositis and dermatomyositis. New Engl J Med 1975; 292: 344-7, 403-407
2. Wilbourn AJ. The electrodiagnostic examination with myopathies. J Clin Neurophysiol 1993; 10: 132-48.
3. Choy HS E, Hoogendijk JE, Lecky B, Winer JB. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis (review). The Cochrane Library 2009, issue 1.
4. Vencovský J, Jarosová K, Machácek S, Studýnková J, Kafková J, Bartůnková J, et al. Cyclosporine A versus metotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol 2000; 29: 95-102. (Pubitemid 30434151)
5. Yamasaki Y, Yamada H, Yamasaki M, Ohkubo M, Azuma K, Matsuoka S, et al. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis. Rheumatology 2007; 46: 124-130
6. Qushmaq KA, Chalmers A, Esdaile JM. Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review. J Rheumatol 2000; 27: 2855-2859
7. Danieli MG, Malcangi G, Palmieri C, Logullo F, Salvi A, Piani M, et al. Cyclosporine A and intravenous immunoglobulin treatment in polymyositis/ dermatomyositis. Ann Rheum Dis 2002; 61: 37-41.
8. Majithia V, Harisdangklu V. Mycophenolate mofetil: an alternative therapy for autoimmune inflammatory myophaty. Rheumatol (Oxford) 2005; 44: 386-389
9. Danieli MG, Calcabrini L, Calabrese V, Marchetti A, Logullo F, Gabrielli A. Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. Autoimmun Rev 2009 (in corso di pubblicazione).
10. Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993; 329: 1993-2000. (Pubitemid 24015043)
11. Danieli MG, Calcabrini L, Marchetti A, Calabrese V, Pettinari L, Massaccesi C, et al. La terapia con immunoglobuline endovena nelle malattie autoimmuni. Recenti Prog Med 2007; 98: 322-326
12. Cherin P, Pelletier S, Teixeira A. Results and long-term follow-up of intravenous immunoglobulin infusions in chronic refractory polymyositis: an open study with 35 adult patients. Arthritis Rheum 2002; 46: 467-474 (Pubitemid 34136585)
13. Feasby T, Banwell B, Benstead T, Bril V, Brouwers M, Freedman M, et al. Guidelines on the use of intravenous immune globuline for neurologic conditions. Transf Med Rev 2007; 21: 67-107.
14. Katz U, Achiron A, Sherer Y, Shoenfeld Y. Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmun Rev 2007; 6: 257-259 (Pubitemid 46274552)
15. Hengestman GJ, Van den Hoogen FH. Treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: long-term follow-up. Eur Neurol 2004; 52: 61-63
16. Mok CC, Ho LY, To CH. Rituximab for refractory polymyositis: an open-label prospective study. J Rheumatol 2007; 34: 1864-1868 (Pubitemid 350067647)